Login / Signup

Benzodiazepines in the oral fluid of Spanish drivers.

Francisco Herrera-GómezMercedes García-MingoFrancisco Javier Álvarez
Published in: Substance abuse treatment, prevention, and policy (2020)
Concomitant use of benzodiazepines and other psychoactive substances was found to be a common behavior among drivers who tested positive on the road. It is important to raise awareness of all those involved in the consumption of driving-impairing substances (authorities, healthcare providers, patients and their families, etc.): roadside detection of driving-impairing substances is suggested, in addition to promoting the use of fewer driving-impairing medications and the provision of clear information to patients.
Keyphrases
  • end stage renal disease
  • healthcare
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • patient reported outcomes
  • health information
  • health insurance